Identifying Factors That Affect Basic Symptoms of Psychosis
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will gather information on the natural history of the basic symptoms of psychosis to identify factors that may affect the improvement or persistence of the symptoms.
| Condition |
|---|
|
Schizophrenia Psychotic Disorders |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Enhancing the Prospective Prediction of Psychosis |
- Information on the natural history of basic symptoms of psychosis [ Time Frame: Measured monthly during Year 1; every 2 months during Year 2; and every 3 months during Years 3, 4, and 5 ] [ Designated as safety issue: No ]
- Factors that may affect the improvement or persistence of basic symptoms of psychosis [ Time Frame: Measured monthly during Year 1; every 2 months during Year 2; and every 3 months during Years 3, 4, and 5 ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Blood samples for routine laboratory studies
| Estimated Enrollment: | 360 |
| Study Start Date: | August 2003 |
| Estimated Study Completion Date: | March 2008 |
| Groups/Cohorts |
|---|
|
1
Participants with basic symptoms of psychosis
|
|
2
Control participants
|
Detailed Description:
Psychosis is a serious mental condition in which a person momentarily loses contact with reality. People in a state of psychosis may experience hallucinations or delusional beliefs that make day-to-day functioning difficult. During the early development of psychosis, people undergo an initial change in mood, thinking, or behavior that may include making mistakes about smells, sounds, or sights; becoming easily distracted; and developing suspicions of others. These basic symptoms can be early warning signs of a brain disorder, including anxiety disorder, depression, or psychotic disorder. Basic symptoms may be due to a number of factors, including a reaction to stress or drugs or just a part of normal adolescence. To identify psychosis early and accurately, more information is needed on the initial stages, biological markers, and progression of psychosis. This study will gather information on the natural history of the basic symptoms of psychosis to identify factors that may affect the improvement or persistence of the symptoms.
Participation in this study will last up to 5 years. The initial screening visit will be used to determine whether a participant is eligible for the group displaying basic symptoms or the control group. Initial screening will include giving a blood sample for routine lab tests, a physical exam, a drug test, and questions about medical history and symptoms. All participants will then partake in baseline evaluations, which involve assessments concerning concentration, problem solving, memory, social skills, and ability to identify smells. Participants will also respond to questions about symptoms, school and social functioning, stressful situations, and family history of illnesses. The participants who meet the criteria for basic symptoms will attend monthly 1-hour follow-up visits for the first year of the study. During these visits, participants will be asked about the status of their basic symptoms and use of medications. For the second year of the study, follow-up visits will occur every 2 months, and for the third, fourth, and fifth years of the study, visits will be every 3 months. Repeat baseline assessments will occur every 6 months, with each assessment visit lasting about 5 hours. All participants will undergo endpoint evaluations that follow the same format as most baseline assessments. Participants who develop a psychotic disorder during the study will attend an additional follow-up visit 6 months after the endpoint evaluation to confirm diagnosis. Participants who decide that they no longer wish to attend regular study visits may be asked to participate in follow-up telephone interviews about their basic symptoms every 6 months.
Eligibility| Ages Eligible for Study: | 12 Years to 35 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
The study population consists of participants who meet the basic symptoms for psychosis and control participants recruited at three sites: the PRIME Clinics at University of North Carolina, Yale University, and the Center for Addiction and Mental Health (CAMH) in Toronto, Canada.
Inclusion Criteria:
- Meets modified criteria of prodromal syndromes (COPS) for schizophrenia prodrome or help-seeking control
Exclusion Criteria:
- History of psychosis
- Antipsychotic treatment in the month prior to study entry
- More than 16 weeks of lifetime antipsychotic treatment
Contacts and Locations| United States, Connecticut | |
| Prevention through Risk Identification Management and Education (PRIME) Clinic | |
| New Haven, Connecticut, United States, 06519 | |
| United States, North Carolina | |
| PRIME Clinic | |
| Chapel Hill, North Carolina, United States, 27599 | |
| Canada, Ontario | |
| PRIME Clinic | |
| Toronto, Ontario, Canada | |
| Principal Investigator: | Scott W. Woods, MD | Yale School of Medicine |
| Principal Investigator: | Jean Addington, PhD | University of Toronto |
| Principal Investigator: | Diana O. Perkins, MD, MPH | University of North Carolina |
More Information
No publications provided
| Responsible Party: | Scott W. Woods, MD, Yale School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00291200 History of Changes |
| Other Study ID Numbers: | MH61282, DATR AD-P |
| Study First Received: | February 10, 2006 |
| Last Updated: | October 16, 2008 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Mental Health (NIMH):
|
Psychosis Basic Symptoms |
Additional relevant MeSH terms:
|
Mental Disorders Psychotic Disorders Schizophrenia Schizophrenia and Disorders with Psychotic Features |
ClinicalTrials.gov processed this record on May 16, 2013